Literature DB >> 29189876

Is ticagrelor safe in intensive care unit patients? Focus on bradycardic events.

Xavier Valette1, Suzanne Goursaud2, Joachim Alexandre3, Maxime Leclerc2, Vincent Roule4, Farzin Beygui4, Damien du Cheyron2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29189876     DOI： 10.1007/s00134-017-5006-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

Review 1.  Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance.

Authors:  Marco Cattaneo; Rainer Schulz; Sven Nylander
Journal:  J Am Coll Cardiol       Date:  2014-04-23       Impact factor: 24.094

2.  The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.

Authors:  Benjamin M Scirica; Christopher P Cannon; Håkan Emanuelsson; Eric L Michelson; Robert A Harrington; Steen Husted; Stefan James; Hugo Katus; Prem Pais; Dimitar Raev; Jindrich Spinar; Ph Gabriel Steg; Robert F Storey; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

3.  Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

Authors:  Laurent Bonello; Marc Laine; Nathalie Kipson; Julien Mancini; Olfa Helal; Julien Fromonot; Vlad Gariboldi; Jocelyne Condo; Franck Thuny; Corinne Frere; Laurence Camoin-Jau; Franck Paganelli; Françoise Dignat-George; Regis Guieu
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

4.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.